Central Serous Chorioretinopathy clinical trials

Explore recruiting central serous chorioretinopathy clinical trials.

Recruiting central serous chorioretinopathy studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Central Serous Chorioretinopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pred Forte® versus placebo eye drops in chronic central serous chorioretinopathy trial (PICS trial)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Central Serous Chorioretinopathy trials by city

Central Serous Chorioretinopathy in Toronto Central Serous Chorioretinopathy in Vancouver Central Serous Chorioretinopathy in Montreal Central Serous Chorioretinopathy in Calgary Central Serous Chorioretinopathy in Edmonton Central Serous Chorioretinopathy in Ottawa Central Serous Chorioretinopathy in Winnipeg Central Serous Chorioretinopathy in Quebec City Central Serous Chorioretinopathy in Hamilton Central Serous Chorioretinopathy in Kitchener Central Serous Chorioretinopathy in London Central Serous Chorioretinopathy in Halifax Central Serous Chorioretinopathy in New York Central Serous Chorioretinopathy in Los Angeles Central Serous Chorioretinopathy in Chicago Central Serous Chorioretinopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease